跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GAILIWELL HUMAN IMMUNOGLOBULIN (PH4) INJ 5% - PPB Drug Approval Details
Approvals
/
PPB
/
GAILIWELL HUMAN IMMUNOGLOBULIN (PH4) INJ 5%
Approved
STANDARD
GAILIWELL HUMAN IMMUNOGLOBULIN (PH4) INJ 5%
GAILY PHARMACEUTICAL COMPANY LIMITED
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
abafef131b6992ad
Company
GAILY PHARMACEUTICAL COMPANY LIMITED
Type
Standard
Approval Details
Approval Id
abafef131b6992ad
Product Name
GAILIWELL HUMAN IMMUNOGLOBULIN (PH4) INJ 5%
Drug Hk Name
GAILIWELL HUMAN IMMUNOGLOBULIN (PH4) INJ 5%
Registration Code
HK-58583
Company Name
GAILY PHARMACEUTICAL COMPANY LIMITED
Company Detail Path
/organization/gaily-pharmaceutical-company-limited
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2009-09-28
Company Address
RM 805 8/F, RM 1414 1415 14/F, LEADER INDUSTRIAL CENTRE, 57-59 AU PUI WAN ST, FO TAN, NEW TERRITORIES
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
abafef131b6992ad
Type
Standard
Back to PPB Approvals